Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11513) 11513
Publication (798) 798
Newsletter (640) 640
Newspaper Article (135) 135
Magazine Article (84) 84
Book Review (39) 39
Book Chapter (11) 11
Conference Proceeding (8) 8
Dissertation (7) 7
Government Document (7) 7
Trade Publication Article (6) 6
Web Resource (2) 2
Book / eBook (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8526) 8526
male (5664) 5664
female (5074) 5074
albuterol - administration & dosage (4084) 4084
albuterol - therapeutic use (3899) 3899
asthma - drug therapy (3758) 3758
albuterol (3667) 3667
adult (3506) 3506
middle aged (2848) 2848
asthma (2802) 2802
albuterol - pharmacology (2665) 2665
administration, inhalation (2460) 2460
respiratory system (2328) 2328
index medicus (2024) 2024
bronchodilator agents - administration & dosage (2021) 2021
albuterol - analogs & derivatives (1990) 1990
bronchodilator agents - therapeutic use (1797) 1797
aged (1750) 1750
salmeterol xinafoate (1724) 1724
double-blind method (1711) 1711
adolescent (1708) 1708
salbutamol (1693) 1693
animals (1673) 1673
child (1597) 1597
asthma - physiopathology (1426) 1426
pharmacology & pharmacy (1376) 1376
nebulizers and vaporizers (1284) 1284
albuterol - adverse effects (1119) 1119
treatment outcome (1068) 1068
drug therapy, combination (1033) 1033
aerosols (1018) 1018
salmeterol (984) 984
adrenergic beta-agonists - therapeutic use (965) 965
dose-response relationship, drug (964) 964
adrenergic beta-agonists - pharmacology (881) 881
adrenergic beta-agonists - administration & dosage (834) 834
child, preschool (834) 834
time factors (830) 830
forced expiratory volume (813) 813
allergy (799) 799
children (779) 779
pediatrics (769) 769
drug therapy (764) 764
forced expiratory volume - drug effects (741) 741
fluticasone (709) 709
research (686) 686
pulmonary disease, chronic obstructive - drug therapy (675) 675
respiratory function tests (666) 666
medicine, general & internal (652) 652
acute disease (628) 628
cross-over studies (627) 627
bronchodilator agents - pharmacology (625) 625
drug combinations (580) 580
immunology (560) 560
infant (558) 558
rats (545) 545
formoterol fumarate (537) 537
analysis (532) 532
antiasthmatic agents (509) 509
heart rate - drug effects (502) 502
bronchodilator agents - adverse effects (495) 495
dosage and administration (492) 492
albuterol - chemistry (488) 488
androstadienes - administration & dosage (487) 487
clinical trials as topic (477) 477
in vitro techniques (472) 472
isoproterenol - pharmacology (469) 469
spirometry (458) 458
care and treatment (453) 453
prospective studies (439) 439
androstadienes - therapeutic use (434) 434
therapy (427) 427
health aspects (406) 406
severity of illness index (404) 404
drug administration schedule (403) 403
critical care medicine (400) 400
respiratory tract diseases (400) 400
particle size (398) 398
administration, oral (392) 392
asthma - diagnosis (392) 392
anti-asthmatic agents - therapeutic use (391) 391
albuterol - pharmacokinetics (386) 386
lung diseases, obstructive - drug therapy (386) 386
formoterol (385) 385
cardiac & cardiovascular systems (382) 382
copd (382) 382
anti-asthmatic agents - administration & dosage (373) 373
inhalation (373) 373
peak expiratory flow rate (372) 372
adrenergic beta-agonists - adverse effects (368) 368
corticosteroids (360) 360
guinea pigs (360) 360
obstructive pulmonary-disease (358) 358
drugs (357) 357
bronchi - drug effects (355) 355
ethanolamines - therapeutic use (354) 354
efficacy (350) 350
bronchial provocation tests (349) 349
lung diseases, obstructive (340) 340
research article (340) 340
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11400) 11400
French (211) 211
German (166) 166
Italian (136) 136
Spanish (115) 115
Polish (83) 83
Chinese (57) 57
Russian (55) 55
Japanese (54) 54
Portuguese (28) 28
Danish (19) 19
Dutch (15) 15
Romanian (12) 12
Croatian (9) 9
Norwegian (8) 8
Turkish (8) 8
Swedish (4) 4
Czech (3) 3
Hebrew (3) 3
Hungarian (3) 3
Korean (3) 3
Serbian (3) 3
Finnish (2) 2
Persian (1) 1
Slovak (1) 1
Slovenian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Phosphodiesterases inhibition unmask a positive inotropic effect mediated by [beta].sub.2-adrenoceptors in rat ventricular myocardium
by Gonzalez-MuA[+ or -]oz, C and Fuente, Teodomiro and Hernandez-Cascales, J
European Journal of Pharmacology, ISSN 0014-2999, 04/2009, Volume 607, Issue 1-3, p. 151
The effects of salbutamol on contractility and cAMP levels were investigated in rat right ventricular myocardium. Salbutamol (1-300 [mu]M), produced a... 
Albuterol
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Effect of graphite and metallic impurities of C.sub.60 fullerene on determination of salbutamol in biological fluids
by Goyal, Rajendra N and Kaur, Davinder and Singh, Sudhanshu P and Pandey, Ashish K
Talanta, ISSN 0039-9140, 03/2008, Volume 75, Issue 1, p. 63
A new method for the determination of salbutamol has been developed using fullerene C.sub.60-modified glassy carbon electrode and validated using GC-MS. The... 
Albuterol
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Can Guideline-defined Asthma Control Be Achieved?: The Gaining Optimal Asthma ControL Study
by Bateman, Eric D and Boushey, Homer A and Bousquet, Jean and Busse, William W and Clark, Tim J. H and Pauwels, Romain A and Pedersen, Soren E and GOAL Investigators Group and GOAL Investigators Grp and GOAL Investigators Group
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 10/2004, Volume 170, Issue 8, pp. 836 - 844
For most patients, asthma is not controlled as defined by guidelines; whether this is achievable has not been prospectively studied. A 1-year, randomized,... 
Antiasthmatic agents | Salmeterol | Fluticasone propionate | Guidelines | Quality of life | antiasthmatic agents | INHALED BUDESONIDE | REALITY | salmeterol | RESPIRATORY SYSTEM | MU-G | fluticasone propionate | guidelines | quality of life | INSIGHTS | CRITICAL CARE MEDICINE | Anti-Asthmatic Agents - adverse effects | Bronchodilator Agents - therapeutic use | Prospective Studies | Asthma - prevention & control | Bronchodilator Agents - administration & dosage | Forced Expiratory Volume - drug effects | Anti-Asthmatic Agents - therapeutic use | Humans | Male | Fluticasone | Adrenal Cortex Hormones - therapeutic use | Dose-Response Relationship, Drug | Time Factors | Albuterol - administration & dosage | Adult | Female | Surveys and Questionnaires | Bronchodilator Agents - adverse effects | Drug Therapy, Combination | Salmeterol Xinafoate | Double-Blind Method | Albuterol - analogs & derivatives | Treatment Outcome | Asthma - drug therapy | Androstadienes - administration & dosage | Quality of Life | Albuterol - therapeutic use | Androstadienes - therapeutic use | Anti-Asthmatic Agents - administration & dosage | Androstadienes - adverse effects | Albuterol - adverse effects | Adrenal Cortex Hormones - administration & dosage | Practice Guidelines as Topic
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text 126 An Observational Study of Albuterol Administration by Basic Life Support Providers
by Morgan, S and Matthews, P and Papas, M.A and Davis, B and Megargel, R
Annals of Emergency Medicine, ISSN 0196-0644, 2016, Volume 68, Issue 4, pp. S50 - S50
To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.annemergmed.2016.08.138 Byline: S. Morgan, P. Matthews, M.A. Papas,... 
Emergency | Albuterol
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Adjuvant oral salbutamol in treatment of juvenile Pompe disease: novel outcome assessment tool and initial report one-year efficacy in single case
by Wood, Michelle and Gissen, Paul and Davison, James E
Molecular Genetics and Metabolism, ISSN 1096-7192, 01/2017, Volume 120, Issue 1-2, pp. S142 - S142
Reports | Albuterol
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text ASM-024, a Piperazinium Compound, Promotes the In Vitro Relaxation of [beta]2-Adrenoreceptor Desensitized Tracheas
by Israel-Assayag, Evelyne and Beaulieu, Marie-Josee and Cormier, Yvon
PLoS ONE, ISSN 1932-6203, 03/2015, Volume 10, Issue 3
Albuterol | Asthma
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text 373 Prospective Exploratory Pilot Study of Hyperlactatemia After Albuterol Therapy
by Ramich, J.L and Timm, E.G and Robak, N and Ata, A and Cohen, J
Annals of Emergency Medicine, ISSN 0196-0644, 2015, Volume 66, Issue 4, pp. S136 - S136
Emergency | Albuterol
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Impact of Salmeterol/Fluticasone Propionate versus Salmeterol on Exacerbations in Severe Chronic Obstructive Pulmonary Disease
by Kardos, Peter and Wencker, Marion and Glaab, Thomas and Vogelmeier, Claus
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 01/2007, Volume 175, Issue 2, pp. 144 - 149
Exacerbations of chronic obstructive pulmonary disease (COPD) greatly contribute to declining health status and the progression of the disease, thereby... 
Exacerbation | Combination treatment | Chronic obstructive pulmonary disease | Inhaled corticosteroids | agonists | Long-acting β | Bronchodilator Agents - therapeutic use | Salmeterol Xinafoate | Bronchodilator Agents - administration & dosage | Double-Blind Method | Drug Administration Schedule | Humans | Middle Aged | Albuterol - analogs & derivatives | Male | Fluticasone | Androstadienes - administration & dosage | Lung - drug effects | Albuterol - administration & dosage | Quality of Life | Albuterol - therapeutic use | Female | Aged | Androstadienes - therapeutic use | Bronchodilator Agents - adverse effects | Drug Therapy, Combination | Androstadienes - adverse effects | Albuterol - adverse effects | Pulmonary Disease, Chronic Obstructive - drug therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma
by Bateman, Eric D., MD and Kornmann, Oliver, MD and Schmidt, Peter, PhD and Pivovarova, Anna, DiplStat and Engel, Michael, MD and Fabbri, Leonardo M., MD
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2011, Volume 128, Issue 2, pp. 315 - 322
Background The efficacy and safety of inhaled long-acting β2 -adrenergic agonists in asthmatic patients with the B16-Arg/Arg genotype has been questioned, and... 
Allergy and Immunology | airway obstruction | agonist receptor | bronchodilators | Arginine/arginine genotype | muscarinic receptor | PREVENTION | PERSISTENT ASTHMA | beta-agonist receptor | IMMUNOLOGY | COMBINATION | BETA-AGONIST | THERAPY | POLYMORPHISMS | FLUTICASONE PROPIONATE | ALLERGY | BROMIDE | ACTING BETA-AGONISTS | COPD | Bronchodilator Agents - therapeutic use | Bronchodilator Agents - administration & dosage | Humans | Male | Arginine - genetics | Albuterol - administration & dosage | Scopolamine Derivatives - administration & dosage | Female | Bronchodilator Agents - adverse effects | Scopolamine Derivatives - therapeutic use | Scopolamine Derivatives - adverse effects | Tiotropium Bromide | Salmeterol Xinafoate | Asthma - physiopathology | Double-Blind Method | Receptors, Adrenergic, beta-2 - genetics | Administration, Inhalation | Albuterol - analogs & derivatives | Genotype | Treatment Outcome | Asthma - drug therapy | Asthma - genetics | Polymorphism, Single Nucleotide - genetics | Albuterol - therapeutic use | Respiratory Function Tests | Peak Expiratory Flow Rate | Albuterol - adverse effects | Antiasthmatic agents | Corticosteroids | Asthma | Studies | Chronic obstructive pulmonary disease | Drug therapy | Drug dosages
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text The Effect of a Holding Chamber on Albuterol Metered-Dose Inhaler Product Differences
by Padron, Grace T and Hernandez-Trujillo, Vivian P
Pediatrics, ISSN 0031-4005, 12/2017, Volume 140, Issue 6, p. S218
Inhalers | Usage | Albuterol
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Functional and biochemical rationales for the 24-hour-long duration of action of olodaterol
by Casarosa, Paola and Kollak, Ines and Kiechle, Tobias and Ostermann, Angela and Schnapp, Andreas and Kiesling, Ralf and Pieper, Michael and Sieger, Peter and Gantner, Florian
Journal of Pharmacology and Experimental Therapeutics, ISSN 0022-3565, 06/2011, Volume 337, Issue 3, pp. 600 - 609
beta(2)-Adrenoceptor (beta(2)-AR) agonists are powerful bronchodilators and play a pivotal role in the management of pulmonary obstructive diseases, such as... 
BETA-ADRENOCEPTOR AGONISTS | FORMOTEROL | OBSTRUCTIVE PULMONARY-DISEASE | ASTHMA | PHARMACOLOGY & PHARMACY | BETA-2-ADRENOCEPTOR AGONIST | SELECTIVITY | BURDEN | BETA-ADRENERGIC RECEPTOR | SALMETEROL | COPD | Adrenergic beta-2 Receptor Agonists - pharmacokinetics | Ethanolamines - pharmacology | Formoterol Fumarate | Bronchodilator Agents - administration & dosage | Albuterol - pharmacology | Humans | Half-Life | Pulmonary Disease, Chronic Obstructive - physiopathology | Ethanolamines - administration & dosage | Adrenergic beta-2 Receptor Agonists - pharmacology | Bronchodilator Agents - chemistry | Ethanolamines - pharmacokinetics | Benzoxazines - pharmacokinetics | Albuterol - administration & dosage | Binding Sites | Benzoxazines - chemistry | Cricetinae | Salmeterol Xinafoate | Benzoxazines - administration & dosage | Adrenergic beta-2 Receptor Agonists - chemistry | Administration, Inhalation | Albuterol - analogs & derivatives | Albuterol - pharmacokinetics | Bronchodilator Agents - pharmacology | Receptors, Adrenergic, beta-1 - metabolism | Ethanolamines - chemistry | Asthma - drug therapy | Receptors, Adrenergic, beta-2 - metabolism | Animals | Bronchodilator Agents - pharmacokinetics | Benzoxazines - pharmacology | Adrenergic beta-2 Receptor Agonists - administration & dosage | Albuterol - chemistry | Mice | Mice, Inbred BALB C | Lipid Bilayers - metabolism | Pulmonary Disease, Chronic Obstructive - drug therapy
Journal Article
Details down arrow
12. Full Text Sulfate radical induced degradation of [beta]2-adrenoceptor agonists salbutamol and terbutaline: Phenoxyl radical dependent mechanisms
by Zhou, Lei and Sleiman, Mohamad and Ferronato, Corinne and Chovelon, Jean-Marc and de Sainte-Claire, Pascal and Richard, Claire
Water Research, ISSN 0043-1354, 10/2017, Volume 123, p. 715
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1016/j.watres.2017.07.025 
Photolysis | Quinone | Albuterol | Sulfates
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Analysis of 10 [beta]-agonists in pork meat using automated dispersive pipette extraction and LC-MS/MS
by Mastrianni, Kaylee R and Metavarayuth, Kalmorat and Brewer, William E and Wang, Qian
Journal of Chromatography B, ISSN 1570-0232, 05/2018, Volume 1084, p. 64
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1016/j.jchromb.2018.03.026 An... 
Analysis | Albuterol | Pork
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Prevalence and progression of osteoporosis in patients with COPD: Results from the towards a revolution in COPD health study
by Ferguson, Gary T and Calverley, Peter M. A and Anderson, Julie A and Jenkins, Christine R and Jones, Paul W and Willits, Lisa R and Yates, Julie C and Vestbo, Jørgen and Celli, Bartolome
Chest, ISSN 0012-3692, 12/2009, Volume 136, Issue 6, pp. 1456 - 1465
Background: Osteoporosis is common in patients with COPD, but its prevalence and progression are not well characterized. Concerns have been raised over the... 
SURVIVAL | FRACTURE | OBSTRUCTIVE PULMONARY-DISEASE | BONE-MINERAL DENSITY | FLUTICASONE PROPIONATE | RESPIRATORY SYSTEM | INHALED CORTICOSTEROIDS | RISK | BUDESONIDE | SEVERITY | SALMETEROL | Bronchodilator Agents - therapeutic use | Bone Diseases, Metabolic - epidemiology | Prevalence | Prospective Studies | Albuterol - pharmacology | United States | Humans | Middle Aged | Fractures, Bone - epidemiology | Male | Fluticasone | Bone Diseases, Metabolic - complications | Female | Bronchodilator Agents - adverse effects | Osteoporosis - epidemiology | Salmeterol Xinafoate | Osteoporosis - chemically induced | Double-Blind Method | Risk Factors | Albuterol - analogs & derivatives | Bronchodilator Agents - pharmacology | Treatment Outcome | Pulmonary Disease, Chronic Obstructive - complications | Bone Diseases, Metabolic - chemically induced | Disease Progression | Bone Density - drug effects | Androstadienes - pharmacology | Osteoporosis - complications | Albuterol - therapeutic use | Aged | Androstadienes - therapeutic use | Fluticasone-Salmeterol Drug Combination | Androstadienes - adverse effects | Albuterol - adverse effects | Drug Combinations | Pulmonary Disease, Chronic Obstructive - drug therapy | Osteoporosis | Complications and side effects | Development and progression | Lung diseases, Obstructive | Corticosteroids | Drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Reported pneumonia in patients with COPD: Findings from the INSPIRE study
by Calverley, Peter M. A and Stockley, Robert A and Seemungal, Terence A. R and Hagan, Gerry and Willits, Lisa R and Riley, John H and Wedzicha, Jadwiga A and INSPIRE Investigators and Investigating New Standards for Prophylaxis in Reduction of Exacerbations (INSPIRE) Investigators
Chest, ISSN 0012-3692, 03/2011, Volume 139, Issue 3, pp. 505 - 512
Background: Pneumonia is an important complication of COPD and is reported more often in patients receiving inhaled corticosteroids (ICSs). Little is known... 
C-REACTIVE PROTEIN | MORTALITY | OBSTRUCTIVE PULMONARY-DISEASE | COMMUNITY-ACQUIRED PNEUMONIA | ANTIMICROBIAL THERAPY | RESPIRATORY SYSTEM | FLUTICASONE PROPIONATE/SALMETEROL 250/50 | INHALED CORTICOSTEROIDS | EXACERBATIONS | RISK | RESPIRATORY-TRACT INFECTIONS | CRITICAL CARE MEDICINE | Bronchodilator Agents - therapeutic use | Bronchodilator Agents - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Male | Fluticasone | Adrenal Cortex Hormones - therapeutic use | C-Reactive Protein - metabolism | Pneumonia - mortality | Pneumonia - chemically induced | Albuterol - administration & dosage | Scopolamine Derivatives - administration & dosage | Female | Bronchodilator Agents - adverse effects | Scopolamine Derivatives - therapeutic use | Scopolamine Derivatives - adverse effects | Tiotropium Bromide | Salmeterol Xinafoate | Double-Blind Method | Pneumonia - epidemiology | Risk Factors | Kaplan-Meier Estimate | Administration, Inhalation | Albuterol - analogs & derivatives | Pulmonary Disease, Chronic Obstructive - complications | Adrenal Cortex Hormones - adverse effects | Androstadienes - administration & dosage | Albuterol - therapeutic use | Aged | Androstadienes - therapeutic use | Androstadienes - adverse effects | Albuterol - adverse effects | Adrenal Cortex Hormones - administration & dosage | Pulmonary Disease, Chronic Obstructive - drug therapy | Complications and side effects | Lung diseases, Obstructive | Usage | Pneumonia | Corticosteroids | Bacterial pneumonia | Research
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
by Calverley, Peter M.A and Anderson, Julie A and Celli, Bartolome and Ferguson, Gary T and Jenkins, Christine and Jones, Paul W and Yates, Julie C and Vestbo, Jørgen and TORCH Investigators and TORCH investigators
The New England Journal of Medicine, ISSN 0028-4793, 02/2007, Volume 356, Issue 8, pp. 775 - 789
This trial involving more than 6000 patients with chronic obstructive pulmonary disease (COPD) compared the effects on all-cause mortality of treatment with an... 
MORTALITY | INHALED CORTICOSTEROIDS | MEDICINE, GENERAL & INTERNAL | Bronchodilator Agents - therapeutic use | Pulmonary Disease, Chronic Obstructive - mortality | Humans | Middle Aged | Male | Risk | Fluticasone | Anti-Inflammatory Agents - adverse effects | Anti-Inflammatory Agents - therapeutic use | Female | Adrenergic beta-Agonists - therapeutic use | Bronchodilator Agents - adverse effects | Drug Therapy, Combination | Adrenergic beta-Agonists - adverse effects | Salmeterol Xinafoate | Double-Blind Method | Administration, Inhalation | Albuterol - analogs & derivatives | Survival Analysis | Albuterol - therapeutic use | Aged | Androstadienes - therapeutic use | Androstadienes - adverse effects | Albuterol - adverse effects | Pulmonary Disease, Chronic Obstructive - drug therapy | Smoking | Lung diseases, Obstructive | Care and treatment | Dosage and administration | Drug therapy | Salmeterol | Mortality | Chronic obstructive pulmonary disease
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. Full Text Tiotropium versus Salmeterol for the Prevention of Exacerbations of COPD
by Vogelmeier, Claus and Hederer, Bettina and Glaab, Thomas and Schmidt, Hendrik and Rutten-van Mölken, Maureen P.M.H and Beeh, Kai M and Rabe, Klaus F and Fabbri, Leonardo M and POET-COPD Investigators
The New England Journal of Medicine, ISSN 0028-4793, 03/2011, Volume 364, Issue 12, pp. 1093 - 1103
An important goal in the treatment of COPD is the prevention of exacerbations. In this trial, the investigators found that treatment with tiotropium, as... 
MEDICINE, GENERAL & INTERNAL | OBSTRUCTIVE PULMONARY-DISEASE | FLUTICASONE PROPIONATE | EFFICACY | TORCH | XINAFOATE | RANDOMIZED CONTROLLED-TRIAL | CARDIOVASCULAR SAFETY | WITHDRAWAL | Bronchodilator Agents - therapeutic use | Glucocorticoids - therapeutic use | Humans | Middle Aged | Male | Adrenergic beta-2 Receptor Agonists - adverse effects | Adrenergic beta-2 Receptor Agonists - therapeutic use | Female | Bronchodilator Agents - adverse effects | Drug Therapy, Combination | Cholinergic Antagonists - adverse effects | Scopolamine Derivatives - therapeutic use | Cholinergic Antagonists - therapeutic use | Scopolamine Derivatives - adverse effects | Tiotropium Bromide | Salmeterol Xinafoate | Double-Blind Method | Pneumonia - epidemiology | Kaplan-Meier Estimate | Proportional Hazards Models | Administration, Inhalation | Albuterol - analogs & derivatives | Pulmonary Disease, Chronic Obstructive - prevention & control | Albuterol - therapeutic use | Aged | Albuterol - adverse effects | Pulmonary Disease, Chronic Obstructive - drug therapy | Prevention | Tiotropium | Lung diseases, Obstructive | Salmeterol | Causes of | Comparative analysis | Drug therapy | Chronic obstructive pulmonary disease | Statistical analysis | Pharmaceutical industry | Mortality
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
18. Full Text Voltammetric behavior of complexation of salbutamol with calf thymus DNA and its analytical application
by Wang, Yingxia and Ni, Yongnian and Kokot, Serge
Analytical Biochemistry, ISSN 0003-2697, 2011, Volume 419, Issue 2, pp. 76 - 80
The interaction of salbutamol (Sal), an animal growth promoter, with DNA was investigated by differential pulse voltammetry (DPV), cyclic voltammetry (CV), and... 
Fluorescence spectroscopy | Voltammetry | Salbutamol | MCR–ALS | DNA | MCR-ALS | CHEMISTRY, ANALYTICAL | ACID | BIOCHEMISTRY & MOLECULAR BIOLOGY | POLAROGRAPHY | BIOCHEMICAL RESEARCH METHODS | MULTIVARIATE CURVE RESOLUTION | NEAR-INFRARED SPECTROSCOPY | ELECTRODE | BINDING | DERIVATIVES | Multivariate Analysis | Oxidation-Reduction | Humans | Spectrometry, Fluorescence | Glass - chemistry | Carbon - chemistry | Albuterol - analysis | Electrodes | DNA - chemistry | Animals | Cattle | Least-Squares Analysis | Albuterol - chemistry | Albuterol - urine | Electrochemical Techniques - methods | Albuterol - blood | Hydrogen-Ion Concentration | Genetic research | Fluorescence | Antiasthmatic agents | Albuterol
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
19. Full Text The structural ba